Voriconazole use for endemic fungal infections

Alison Freifeld, Laurie Proia, David Andes, Larry M. Baddour, Janis Blair, Brad Spellberg, Sandra Arnold, Arnold Lentnek, L. Joseph Wheat

Research output: Contribution to journalArticlepeer-review

94 Scopus citations


In a retrospective review of 24 patients with histoplasmosis, blastomycosis, or coccidioidomycosis treated with voriconazole (most for salvage therapy), the outcome was favorable (improved or stable) for 22 (95.8%) within 2 months of starting voriconazole and for 20 (83.3%) at the last follow-up. Prospective studies are required to determine its role in the treatment of endemic mycoses.

Original languageEnglish (US)
Pages (from-to)1648-1651
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Issue number4
StatePublished - Apr 2009

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases


Dive into the research topics of 'Voriconazole use for endemic fungal infections'. Together they form a unique fingerprint.

Cite this